Sera Prognostics, Inc. (SERA) vs Zomedica Corp. (ZOMDF)
Sera Prognostics, Inc. and Zomedica Corp. are both Medical Devices companies. Zomedica Corp. is the larger, with a market value of $95.4M against $83.2M — 1.1× the size. Zomedica Corp. grew revenue faster over the last twelve months: 30.1% against −35.2%. Zomedica Corp. has the higher net margin (−51.4% vs −47,475.7%) and the higher return on invested capital (−20.5% vs −180.2%). Across the 16 metrics below, Zomedica Corp. leads on 15 and Sera Prognostics, Inc. on 1.
Valuation
Profitability
| Metric | SERA | ZOMDF | Medical Devices median |
|---|---|---|---|
| Gross margin | (150.00%) | 65.44% | 56.01% |
| Operating margin | (53,282.86%) | (56.28%) | (15.03%) |
| Net margin | (47,475.71%) | (51.39%) | (20.40%) |
| Free cash flow margin | (40,760.00%) | (40.75%) | (7.24%) |
| Return on equity | (45.03%) | (16.29%) | (15.32%) |
| Return on assets | (33.47%) | (14.88%) | (19.72%) |
| Return on invested capital | (180.22%) | (20.54%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack